Skip to main content
Log in

A New Approach to Decrease Serum Cholesterol Levels

  • Editorial
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Zhao SP, Liu L, Cheng YC, Shishehbor MH, Liu MH, Peng DQ, Li YL. Xuezhikang, an extract of cholestin, protects endothelial function through anti-inflammatory and lipid-lowering mechanisms in patients with coronary heard disease. Circulation 2004;110:915–20.

    Article  PubMed  Google Scholar 

  2. McGowan MP, Treating to New Target Study Group. There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation 2004;110(16):2333–5, Oct 19.

    Article  PubMed  CAS  Google Scholar 

  3. Robinson JG, Smith B, Maheshwari N, Schrott H. Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis. J Am Coll Cardiol 2005;46(10):1855–62.

    Article  PubMed  CAS  Google Scholar 

  4. http://www.fda.gov/.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric Bruckert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruckert, E. A New Approach to Decrease Serum Cholesterol Levels. Cardiovasc Drugs Ther 20, 157–158 (2006). https://doi.org/10.1007/s10557-006-8800-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-006-8800-y

Navigation